Tennessee-based addiction treatment companies ReVIDA Recovery Centers and Cedar Recovery have been selected by the Centers for Medicare and Medicaid Services to participate in a four-year demonstration exploring new payments and delivery models in treating patients with opioid use disorder.
The trial seeks to increase access to addiction treatment services and improve physical and mental outcomes for Medicare Fee-For-Service beneficiaries, according to CMS, while attempting to reduce expenditures for the safety-net payer.
ReVIDA and Cedar Recovery will now receive two new Medicare payments for participating in the demonstration, including a per-beneficiary, per-month care management fee and a performance-based incentive payment.